Seeta Eye Centers alerted women who experience an early onset of menopause that they may be at greater risk of developing glaucoma according to a study at the Netherlands Ophthalmic Research Institute in Amsterdam. In this study of more than 3,000 women, those who went through a natural menopause before the age of 45 were more than twice as likely to be diagnosed with open-angle glaucoma as women who went through menopause at age 50 or older.
The results indicate that female hormones may be protective against open-angle glaucoma, a leading cause of blindness. Of interest is that hormone replacement therapy (HRT) is thought to reduce fluid pressure inside the eye. Similarly, as hormone levels rise during pregnancy, fluid pressure inside the eye decreases significantly, the researchers noted. This is the first study to examine the relationship between female sex hormones, as indicated by age of menopause, and open-angle glaucoma.
If you or someone you know has questions about early menopause and glaucoma risk or needs an eye exam for glaucoma please feel free to call Seeta Eye Centers and schedule an eye examination by calling 845-454-1025, visiting Seeta Eye Centers or facebook.com/seetaeyecenters.
Seeta Eye Centers is conveniently located at 23 Davis Avenue, Poughkeepsie, New York 12603, Cecilwood Health Center, 969 Main Street, Fishkill, New York 12524 and 664 Stoneleigh Avenue, Suite 100, Carmel, New York 10512 for patients from Westchester County, Rockland County and throughout the Hudson Valley, Dutchess County and Orange County.
Seeta Eye Centers in NY blog for information about cataracts, bladeless laser cataract surgery & lens implants, bladeless LASIK, diabetic retinopathy, macular degeneration, glaucoma, laser eye surgery, eye health and vision for New York eye care patients.
Thursday, February 20, 2014
Monday, February 10, 2014
Inflammation Marker Indicates Macular Degeneration Risk
A blood test that marks inflammation, called CRP (c-reactive
proteins) appears to be a useful indicator of your risk of Age Related MacularDegeneration (AMD). Researchers from Harvard Medical School and Brigham and
Women’s Hospital in Boston reporting in JAMA Ophthalmology that the risk of macular degeneration
(AMD) is directly correlated with the findings of the CRP (c-reactive proteins)
test in men and women. The study findings across the groups showed that there
was a significantly increased risk of AMD for those patients with high versus
low CRP levels and those with high CRP levels also had a significantly
increased risk of neovascular or Wet AMD which is responsible for instances of
catastrophic vision loss.
The researchers
concluded that elevated levels of CRP predict greater future risk of AMD. It is
believed that this information might shed light on underlying mechanisms and
could be of clinical help in the identification of persons at high risk of AMD
who may benefit from increased adherence to lifestyle recommendations, eye
examination schedules and therapeutic protocols.
If you or someone you know has questions about
inflammation markers such as CRP and the risk of Age Related MacularDegeneration (AMD) please feel free to call Seeta Eye Centers and schedule an
eye examination by calling 845-454-1025, visiting Seeta Eye Centers or facebook.com/seetaeyecenters.
Seeta Eye Centers is
conveniently located at 23
Davis Avenue, Poughkeepsie, New York 12603, Cecilwood Health Center, 969 Main Street, Fishkill, New
York 12524 and 664 Stoneleigh Avenue, Suite 100, Carmel, New York 10512 for patients from Westchester County,
Rockland County and throughout the Hudson Valley, Dutchess County and
Orange County.
Monday, February 3, 2014
Seniors Need Better Macular Degeneration Awareness
Age Related Macular Degeneration (AMD) is a leading cause of vision loss in seniors and in fact it is estimated that more than 2 million people age 50 and older have late AMD (Age Related Macular Degeneration), a cause of potentially catastrophic vision loss. With early detection, diagnosis and treatment, at a minimum we can prevent further vision loss from the disease and in many cases we can actually help recover lost vision.
About Age Related Macular Degeneration(AMD)
Vision loss from AMD is progressive and painless typically causing a loss of central vision but leaving peripheral vision intact. There are two types of AMD, a “Dry” form and a “Wet” form. It is estimated that 85-90% of people with AMD have the Dry form which results in a gradual vision loss, whereas only 10 percent of people with AMD have the Wet form which progresses much quicker and can cause catastrophic vision loss.
Vision loss from AMD is progressive and painless typically causing a loss of central vision but leaving peripheral vision intact. There are two types of AMD, a “Dry” form and a “Wet” form. It is estimated that 85-90% of people with AMD have the Dry form which results in a gradual vision loss, whereas only 10 percent of people with AMD have the Wet form which progresses much quicker and can cause catastrophic vision loss.
Symptoms of Age Related Macular Degeneration (AMD)
Wet AMD is characterized by the growth of abnormal retinal blood vessels that leak blood or fluid under and into the Retina. Leaking or bleeding vessels leads to swelling and bleeding in the Macula-the center of the Retina, causing visual distortions or decreased vision. Over time, this can lead to scarring in the Macula and create damage that may result in the loss of central vision.
Wet AMD is characterized by the growth of abnormal retinal blood vessels that leak blood or fluid under and into the Retina. Leaking or bleeding vessels leads to swelling and bleeding in the Macula-the center of the Retina, causing visual distortions or decreased vision. Over time, this can lead to scarring in the Macula and create damage that may result in the loss of central vision.
Preventing Age Related Macular Degeneration(AMD)
Patients can often reduce their risk of developing AMD by not smoking as well as eating a heart-healthy diet rich in fish, fruit and green leafy vegetables, avoiding foods with Trans fats, limiting alcohol consumption, exercising and controlling blood pressure and weight.
If you or someone you know has questions about their risk of agerelated macular degeneration (AMD) or needs an eye exam for AMD please feel free to call Seeta Eye Centers and schedule an eye examination by calling 845-454-1025, visiting Seeta Eye Centers or facebook.com/seetaeyecenters.
Seeta Eye Centers is conveniently located at 23 Davis Avenue, Poughkeepsie, New York 12603, Cecilwood Health Center, 969 Main Street, Fishkill, New York 12524 and 664 Stoneleigh Avenue, Suite 100, Carmel, New York 10512 for patients from Westchester County, Rockland County and throughout the Hudson Valley, Dutchess County and Orange County.
Patients can often reduce their risk of developing AMD by not smoking as well as eating a heart-healthy diet rich in fish, fruit and green leafy vegetables, avoiding foods with Trans fats, limiting alcohol consumption, exercising and controlling blood pressure and weight.
What patients need to be aware of is that once you are over 50, it becomes increasingly important to have a thorough, comprehensive dilated eye exam every one to two years-and even more often if you have any family history of AMD or at the recommendation of your eye doctor. The key to preventing vision loss from AMD is clearly early detection, quick diagnosis and then immediate access to treatment with vascular endothelial growth inhibitor (VEGF) injections such as Lucentis® or Eylea®.
Seeta Eye Centers is conveniently located at 23 Davis Avenue, Poughkeepsie, New York 12603, Cecilwood Health Center, 969 Main Street, Fishkill, New York 12524 and 664 Stoneleigh Avenue, Suite 100, Carmel, New York 10512 for patients from Westchester County, Rockland County and throughout the Hudson Valley, Dutchess County and Orange County.
Subscribe to:
Posts (Atom)